Genomic Biomarker Market is expected to increase at a compound annual growth rate (CAGR) of 11.6% from 2025 to 2035
The genomic biomarker market is expected to increase at a compound
annual growth rate (CAGR) of 11.6% from 2025 to 2035, from its estimated USD
26.78 billion in 2024 to USD 89.56 billion. In the field of personalized
medicine, which aims to maximize therapeutic approaches and minimize adverse
effects by understanding each individual's unique genetic composition, the idea
of genomic biomarkers has grown in popularity.
A DNA or RNA
feature that indicates normal biological processes, pathogenic processes,
and/or responsiveness to therapeutic or other interventions is called a genomic
biomarker. These measurable factors predict therapy responses, provide
quantifiable evidence of treatment efficacy, or reveal hereditary vulnerability
to the disease.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/genomic-biomarker-market
GROWTH
DRIVERS
Genetic testing
for cancer, uncommon diseases, and inherited disorders is becoming more common
in the pharmaceutical sector. In oncology, genomic biomarkers are essential for
tumor profiling, minimum residual disease (MRD) testing, and liquid biopsies, which
help match patients with immunotherapies and targeted medicines. For instance,
the quick uptake of these technologies has made cancer the leading market
segment for genetic biomarkers.
There is a
growing need for accurate and quick diagnostic tools due to the global rise in
the prevalence of chronic illnesses like cancer, heart disease, and
neurological problems. Genomic biomarkers offer a degree of precision that
traditional methods often lack, leading to improved patient care and more
effective therapeutic strategies.
MARKET
SEGMENTATION:
By Product
Type -
o Assay
Kits
o Reagents
& Chemicals
o Columns
& Filters
· Services
· Software
By Type –
· Safety
Biomarkers
· Efficacy
Biomarkers
· Predictive
Biomarkers
· Surrogate
Biomarkers
· Pharmacodynamics
Biomarkers
· Prognostic
Biomarkers
· Validation
Biomarker
By
Technology –
· Next-Generation
Sequencing (NGS)
· Polymerase
Chain Reaction (PCR)
· Microarrays
· Genomic
Hybridization
· Other Technologies
By
Application –
· Oncology
· Rare Genetic Disorders & Metabolic
Diseases
· Infectious
Diseases
· Immunological
Disorders
· Neurological
Disorders
· Cardiovascular
Disorders
· Autoimmune & Inflammatory Disorders
· Pharmacogenomics & Personalized
Medicine
· Other
Disease Indication
By End
User –
· Hospitals
& Clinical Diagnostic Laboratories
· Pharmaceutical
& Biotechnology Companies
· Academic
& Research Institutes
· Contract
Research Organizations (CROs) & Contract Development and Manufacturing
Organizations (CDMOs)
· Other End Users
By Region -
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East & Africa
Key
Players:
· Bio-Rad
Laboratories
· Almac
Group
· Eurofins
Scientific
· Thermo
Fisher Scientific Inc
· Epigenomics
AG
· Roche
Diagnostics
· Myriad
Genetics
· QIAGEN
· Other
Key & Niche Players
For More Information about this Report @
https://www.xresearch.biz/shop/genomic-biomarker-market
About Us: -
xResearch is a market research and consulting
organization that uses unique data, expert analysis, and new technologies to
create trusted intelligence on industries. Our research is focused on
delivering an informed and impartial view on essential market data of industry,
and it is primarily driven by an in-depth study covering the following
parameters: Market Sizing and Forecasting, Market Segmentation, Competitive
Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/
Comments
Post a Comment